Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Effect of acupuncture pretreatment on clinical pregnancy rate in women with diminished ovarian reserve undergoing IVF-ET: study protocol for a multicenter randomized controlled trial

Title: Effect of acupuncture pretreatment on clinical pregnancy rate in women with diminished ovarian reserve undergoing IVF-ET: study protocol for a multicenter randomized controlled trial
Authors: Xin Liu; Chenchen Su; Junmin Li; Li Chen; Qinhua Zhang; Yan Sun; Jinbang Xu; Cuilian Zhang; Xinjie Cheng; Xuemei Li; Huisheng Yang; Yicong Xie; Jie Yang; Na Zhu; Weiying Lu; Tongsheng Su; Wei Shang; Qun Lu; Li Yang; Jiashan Li; Tian Hang; Lingyu Qi; Qiwei Xiao; Weixin Li; Feng Gao; Xiaoyan Wang; Pengfei Du; Dongxue An; Huanfang Xu; Yigong Fang
Source: Frontiers in Endocrinology, Vol 17 (2026)
Publisher Information: Frontiers Media S.A.
Publication Year: 2026
Collection: Directory of Open Access Journals: DOAJ Articles
Subject Terms: acupuncture; clinical pregnancy rate; diminished ovarian reserve; in vitrofertilization-embryo transfer; multi-center; randomized controlled trial; Diseases of the endocrine glands. Clinical endocrinology; RC648-665
Description: IntroductionDiminished ovarian reserve (DOR) is known to reduce the likelihood of achieving pregnancy or live births in women undergoing in vitro fertilization and embryo transfer (IVF-ET). Acupuncture maybe effective for DOR, but current evidence remains limited and inconclusive.Methods and analysisThis study is a multicenter, randomized, placebo-controlled trial conducted on a large scale. A total of 300 women with DOR preparing for IVF-ET will be randomized 1:1 to acupuncture or placebo acupuncture. Interventions will be administered from the second menstrual cycle preceding the IVF cycle until the day of oocyte retrieval. The primary outcome is the clinical pregnancy rate (CPR) following the first embryo transfer. Secondary outcomes include various IVF-ET indicators, such as the number of follicles ≥ 14 mm, estradiol (E2) levels, and endometrial thickness on the day of human chorionic gonadotropin (hCG) administration; the number of retrieved oocytes, metaphase II (MII) oocytes, and two pronuclei (2PN) fertilizations; as well as the rates of 2PN fertilization, available embryos, high-quality embryos, implantation, cycle cancellation, biochemical pregnancy, pregnancy loss, sustained pregnancy, and live birth. Additionally, ovarian reserve indicators—including antral follicle count (AFC), basal serum levels of follicle-stimulating hormone (FSH), luteinizing hormone (LH), and E2, and anti-Müllerian hormone (AMH)—along with scores from the Self-Rating Anxiety Scale (SAS) will also be evaluated.Ethics and disseminationThe trial has been approved by the ethics committees of all participating centers. The results will be disseminated in academic journals.Clinical Trial Registrationhttp://itmctr.ccebtcm.org.cn/, identifier ID: ITMCTR2024000021.
Document Type: article in journal/newspaper
Language: English
Relation: https://www.frontiersin.org/articles/10.3389/fendo.2026.1723278/full; https://doaj.org/toc/1664-2392; https://doaj.org/article/462a246e39824098b614e420dc5c92c0
DOI: 10.3389/fendo.2026.1723278
Availability: https://doi.org/10.3389/fendo.2026.1723278; https://doaj.org/article/462a246e39824098b614e420dc5c92c0
Accession Number: edsbas.9775440E
Database: BASE